Skip to content

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review

Alina Wilkowska, Łukasz P. Szałach, Jakub Słupski, Aleksandra Wielewicka, Małgorzata Czarnota, Maria Gałuszko‐węgielnik, Mariusz S. Wiglusz, Wiesław Jerzy Cubała

Frontiers in Psychiatry June 3, 2020 DOI: 10.3389/fpsyt.2020.00516 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population Bipolar I disorder patient with treatment-resistant depressive episode
Intervention oral ketamine
Dose subanaesthetic doses
Topics Depression Ketamine Esketamine
Keywords Bipolar disorder Depression economics Depressive symptoms Mania Lithium medication Cognition
Citations 9
Key findings A patient with bipolar I disorder experienced a switch to a manic episode with mixed features after receiving eight subanaesthetic doses of oral ketamine as an add-on treatment.

Abstract

There is a growing evidence for the rapid and robust antidepressive effect of ketamine in unipolar and bipolar treatment resistant depression although evidence for the risk of affective switch is still limited. This case presents bipolar I disorder patient with treatment resistant depressive episode experiencing a switch to manic episode with mixed features shortly after receiving eight subanaesthetic doses of oral ketamine as an add-on treatment preceded by 2-day period of manic symptoms.

Explore topics